Alex Shirazi sits down with Dr. Miotto and Leo Groenewegen to chat about the exciting new developments from CellulaREvolution, based in the UK. Dr. Martina Miotto and is the co-founder and Chief Scientific Officer at CellulaREvolution Ltd. She began her studies at the University of Ferrara (Italy), where she completed a BSc in Biotechnology and a MSc in Biomolecular and Cellular Sciences. Subsequently, she moved to Newcastle University (UK) where she completed her PhD in corneal tissue engineering and a significant part of this involved the development of the technology underpinning CellulaREvolution. Following her successful PhD, Dr Miotto has focussed firmly on a commercial career pathway. She initially received a Newcastle University Enterprise Scholarship, followed by an ICURe Fellowship to explore further the market and value proposition. Afterwards, she was awarded an Enterprise Fellowship by the Royal Society of Edinburgh to receive mentoring and training in the business sector. Since the spin-out of CellulaREvolution from the University in July 2019, Martina has led the scientific development of the company. Leo Groenewegen is co-founder Chief Executive Officer at CellulaREvolution Ltd. Leo has extensive experience in the fields of Biotech and Pharmaceuticals. During his career he has enabled a wide array of firms to out-perform by achieving scientific, financial and commercial excellence. As Chief Executive Officer, Leo ensures that the overall goals of the company are achieved. Leo Groenewegen has previously held a position as CFO at a Swedish based biotech company, where besides financing he was also responsible for Investor relations, PR/Communications and Business Development. Some of his other experiences included positions at reputable consulting firms such as IMS Health and Deloitte.